why choose us

Clinical Trials Search

Showing 9,910 of 132,963 result(s)
Subcutaneous Abatacept in Renal Transplant Recipients

Status: COMPLETED

Condition: Kidney Transplant Recipient

Interventions:

Participants on qualifying belatacept regimen (with low dose tacrolimus, mmf and prednisone) will have their maintenance regimen changed from i.v.<

Date: 2023-07-26

Acupuncture for Prevention of Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy

Status: COMPLETED

Condition: Cholecystitis, Acute

Interventions: Acupuncture at points points PC 6 bilaterally, LI 4 bilaterally, and Yin Tang

Date: 2023-07-26

New MRI Techniques for Diagnosis and Treatment of Patients With Abdominal Aortic Aneurysms

Status: COMPLETED

Condition: Abdominal Aortic Aneurysm Without Rupture

Interventions: Philips Ingenia 3.0T MR system with in-house developed PROUD software

Date: 2023-07-26

Dialectical Behavior Therapy for Justice-Involved Veterans

Status: NOT_YET_RECRUITING

Condition: Criminal Behavior

Interventions: 16 weeks of Dialectical Behavior Therapy for Justice-Involved Veterans, including weekly 60-minute group therapy and biweekly 30-minute individual cas

Date: 2023-07-26

Pre vs Post Block in Total Knee Arthroplasty (TKA)

Status: Completed

Condition: Knee Osteoarthritis

Interventions: Dexamethasone 10mg administered via IV once postoperatively within 24 hours for pain and swelling

Date: 2023-07-26

Considering Racial and Acculturation Stress in Addressing Trauma

Status: Completed

Condition: Trauma-related PTSD

Interventions: TF-CBT is an evidence-based treatment for children and adolescents impacted by trauma and their parents or caregivers.
It is a components-based t

Date: 2023-07-26

Rib Fracture Cryoanalgesia

Status: Completed

Condition: Pain Management Improvement

Interventions: the use of surgical procedure that produces lesions in peripheral nervous tissue through application of extreme cold

Date: 2023-07-26

A Study to Evaluate the Safety and Immunogenicity of mRNA-1975 and mRNA-1982 Against Lyme Disease in Participants 18 Through 70 Years of Age

Status: ACTIVE_NOT_RECRUITING

Condition: Lyme Disease

Interventions: Dispersion delivered IM

Date: 2023-07-26

Safety and Efficacy of Venetoclax in Idiopathic Pulmonary Fibrosis

Status: Completed

Condition: Idiopathic Pulmonary Fibrosis

Interventions: 100 mg daily by mouth for 3 weeks This drug inhibits a protein (Bcl-2) that protects cells from undergoing programmed cell death.

Date: 2023-07-26